We are live on ! Find out more
Nuveen

Nuveen Portfolio holdings

AUM $419B
1-Year Est. Return 43.02%
This Fund
S&P 500
This Quarter Est. Return
+13.71%
1 Year Est. Return
+43.02%
3 Year Est. Return
+139.43%
5 Year Est. Return
+185.66%
10 Year Est. Return
+615.13%
AUM
$311B
AUM Growth
+$27B
Cap. Flow
-$2.73B
Cap. Flow %
-0.88%
Top 10 Hldgs %
26.14%
Holding
3,413
New
219
Increased
1,869
Reduced
1,057
Closed
98

Top Buys

Rank Stock Value
1
CRH icon
CRH
CRH
+$482M
2
SHOP icon
Shopify
SHOP
+$353M
3
INTC icon
Intel
INTC
+$318M
4
NKE icon
Nike
NKE
+$312M
5
UBS icon
UBS Group
UBS
+$309M

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$520M
2
ORCL icon
Oracle
ORCL
+$471M
3
CRM icon
Salesforce
CRM
+$452M
4
EOG icon
EOG Resources
EOG
+$360M
5
META icon
Meta Platforms (Facebook)
META
+$246M

Sector Composition

Rank Sector Weight
1 Technology 28.65%
2 Financials 12.19%
3 Healthcare 11.71%
4 Consumer Discretionary 11.15%
5 Industrials 8.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VIGL
3251
DELISTED
Vigil Neuroscience
VIGL
$90.7K ﹤0.01%
26,840
+2,125
+9% +$10.9K
PRTH icon
3252
Priority Technology Holdings
PRTH
$642M
$89.6K ﹤0.01%
25,156
– –
DAO
3253
Youdao
DAO
$1.79B
$89K ﹤0.01%
22,600
– –
TVRD
3254
Tvardi Therapeutics
TVRD
$17.1M
$84.7K ﹤0.01%
3,165
+30
+1% +$1.24K
CANO
3255
DELISTED
Cano Health, Inc.
CANO
$82.3K ﹤0.01%
+14,022
New +$166K
KYNB
3256
Kyntra Bio
KYNB
$27.9M
$73.6K ﹤0.01%
3,324
– –
PRLD icon
3257
Prelude Therapeutics
PRLD
$310M
$71.7K ﹤0.01%
16,797
+2,993
+22% +$9.11K
IMA
3258
ImageneBio Inc
IMA
$53.6M
$71.6K ﹤0.01%
3,027
+275
+10% +$8.97K
AMPX icon
3259
Amprius Technologies
AMPX
$1.43B
$69.1K ﹤0.01%
+13,071
New +$49.1K
ZVIA icon
3260
Zevia
ZVIA
$95.2M
$68.7K ﹤0.01%
34,161
– –
UONEK icon
3261
Urban One Class D
UONEK
$17.1M
$66.3K ﹤0.01%
1,880
+394
+27% +$18K
LNSR icon
3262
LENSAR
LNSR
$86.2M
$62.7K ﹤0.01%
17,865
– –
ACRV icon
3263
Acrivon Therapeutics
ACRV
$90M
$58.2K ﹤0.01%
11,821
– –
VAXX
3264
DELISTED
Vaxxinity, Inc. Class A Common Stock
VAXX
$49.3K ﹤0.01%
58,029
– –
UONE icon
3265
Urban One Class A
UONE
$19.5M
$47.2K ﹤0.01%
1,171
– –
BTAI
3266
DELISTED
BioXcel Therapeutics
BTAI
$43.7K ﹤0.01%
926
– –
WHWK
3267
Whitehawk Therapeutics
WHWK
$214M
$42.2K ﹤0.01%
20,913
– –
CCLP
3268
DELISTED
CSI Compressco LP
CCLP
$37.7K ﹤0.01%
23,150
– –
CRGE
3269
DELISTED
Charge Enterprises, Inc. Common Stock
CRGE
$37.4K ﹤0.01%
327,925
+2,813
+0.9% +$764
DFLI icon
3270
Dragonfly Energy
DFLI
$13.8M
$34.9K ﹤0.01%
715
+289
+68% +$21.9K
CMAX
3271
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
$29.6K ﹤0.01%
1,984
– –
OKUR
3272
OnKure Therapeutics
OKUR
$118M
$28.9K ﹤0.01%
1,804
+118
+7% +$7.35K
BGXX
3273
DELISTED
Bright Green Corporation Common Stock
BGXX
$27.3K ﹤0.01%
82,701
– –
LSF icon
3274
Laird Superfood
LSF
$39.5M
$20.6K ﹤0.01%
22,636
– –
RAIN
3275
DELISTED
Rain Oncology Inc. Common Stock
RAIN
$20.1K ﹤0.01%
+16,731
New +$18.1K

Similar funds

Nuveen's Q4 2023 Portfolio in Review

As of Q4 2023, Nuveen held 3,413 positions worth $311B, up 9.5% from $284B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Nuveen's Q4 2023 filing shows 219 new, 1,869 increased, 1,057 reduced and 98 closed positions. Its largest new stake was CRH: 7,989,897 shares worth $552M. The largest sale was Amazon, an estimated $520M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 27% a quarter earlier, followed by Financials and Healthcare.

  • Nuveen's largest Q4 2023 buy was CRH: 7,989,897 shares worth $552M.
  • Nuveen added most to Intel in Q4 2023, an estimated $318M increase.
  • Nuveen's biggest Q4 2023 reduction was Amazon, cutting an estimated $520M.
  • Nuveen fully exited Activision Blizzard in Q4 2023, selling an estimated $194M.
  • Nuveen's ten largest holdings make up 26% of its $311B portfolio in Q4 2023.
  • Nuveen opened 219 new positions and closed 98 in Q4 2023.
  • Nuveen's portfolio value rose 9.5% quarter-over-quarter to $311B.

Based on Nuveen's 13F filing for Q4 2023, filed 14 Feb 2024.